Skip to main content

FDA Approves Long-Awaited Cholesterol Drugs

Federal regulators have signed off on a new drug that lowers cholesterol, a development that could bring an important but costly new medical tool to fighting heart disease.

Republish
Lead image for this article

Federal regulators have signed off on a new drug that lowers cholesterol, a development that could bring an important but costly new medical tool to fighting heart disease. The drugs — which could benefit millions — are an alternative to the much-cheaper statins, the common cholesterol-lowering drug that might not be adequate for some. (Wall Street Journal) 

Wait! We need your help.

More than 2 million people read Texas Tribune articles every month, but only 12,000 of those readers also donate to support the news they count on. Not even 1% of readers! If you are one of the 99% of Texas Tribune readers who hasn’t made a donation before in support of independent Texas news, you can change that today. A small donation makes a big impact.

Our Spring Member Drive is an important time to help our newsroom plan for what resources will be available for them to tackle longer investigations and bigger projects later this year. Texas Tribune journalists need the support of readers to write the articles, take the photographs and create the data visualizations that impact Texans and Texas policy.

We have a goal to have 500 readers become Texas Tribune members during our Spring Member Drive. As the Tribune member community grows, the journalism you read here is better protected. Will you make a donation today to show your support of independent Texas news?

DONATE NOW

Information about the authors

Learn about The Texas Tribune’s policies, including our partnership with The Trust Project to increase transparency in news.

Explore related story topics